Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease
Frontiers in Bioscience-Landmark · 19.05.2026 · 31 (5)
DOI: 10.31083/fbl49006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 19.05.2026. Verfasst von Hanqing Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education…. Hauptthemen laut MEDLINE: Efferocytosis, Macrophages, Homeostasis, Cardiovascular Diseases. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), National Science and Technology Major Project for Prevention and Treatment Research of Cancer, Cardio-cerebrovascular, Respiratory and Metabolic Diseases, Youth Talent Lifting Project of China Association of Chinese Medicine.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are the primary cause of mortality globally. The Global Burden of Disease Study indicates that CVDs account for one-third of all global deaths, with a notable 18.17% increase in their incidence over the last decade. Despite the widespread use and proven effectiveness of therapies like antiplatelet agents, lipid-lowering drugs, anticoagulants, and percutaneous coronary intervention (PCI) in managing risk factors, the long-term prognosis of patients remains suboptimal. The prevailing academic viewpoint asserts that chronic inflammation and dysregulated apoptosis lead to the accumulation of apoptotic cells or fragments, triggering inflammatory injury and oxidative stress. Efferocytosis, encompassing the recognition, engulfment, and degradation of apoptotic cells by phagocytes, is essential for preserving tissue homeostasis and limiting excessive inflammation in this context. Macrophages, being professional phagocytes, demonstrate the highest efficiency and precision in clearing apoptotic cells. Hence, this review will center on macrophage-mediated efferocytosis, systematically investigating its roles and mechanisms in the pathogenesis and progression of CVDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education, Tianjin University of Traditional Chinese Medicine, 301617 Tianjin,…
- National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 300193 Tianjin, China.
Förderung
- National Natural Science Foundation of China (NSFC)
- National Science and Technology Major Project for Prevention and Treatment Research of Cancer, Cardio-cerebrovascular, Respiratory and Metabolic Diseases
- Youth Talent Lifting Project of China Association of Chinese Medicine
Zitieren
APA
Lin, H., Zhu, X., Sun, Y., Yang, Y., Fan, A., Yang, K., Gao, Z., Ma, C., Fan, G., & Li, L. (2026). Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease. Frontiers in Bioscience-Landmark, 31(5). https://doi.org/10.31083/fbl49006
Vancouver
Lin H, Zhu X, Sun Y, Yang Y, Fan A, Yang K, et al. Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease. Frontiers in Bioscience-Landmark. 2026;31(5). doi:10.31083/fbl49006
BibTeX
@article{Lin2026,
author = {Lin, Hanqing and Zhu, Xiangyu and Sun, Yuting and Yang, Yakun and Fan, Aodi and Yang, Ke and Gao, Zixuan and Ma, Chuanrui and Fan, Guanwei and Li, Lan},
title = {Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {5},
doi = {10.31083/fbl49006}
}
EUVIMED